ライフサイエンスコーパス: serum albumin

1 hibition with a CCD inhibitor (MUXF(3)-human serum albumin).

2 m was measured at baseline and corrected for serum albumin.

3 f binding between the lipidated peptides and serum albumin.

4 n combination of calcium alginate and bovine serum albumin.

5 r secretion without the presence of serum or serum albumin.

6 y thrombin inhibitors alone, as well as with serum albumin.

7 rotein was slightly heavier than the mass of serum albumin.

8 t, and its washout was accelerated by bovine serum albumin.

9 ated when SWCNTs were pre-coated with bovine serum albumin.

10 vitro by exposure to a single host protein, serum albumin.

11 ding between the peptide oligomers and human serum albumin.

12 s that have been covalently linked to bovine serum albumin.

13 e chromatography based purification of human serum albumin.

14 ome c, 90% for myoglobin, and 65% for bovine serum albumin.

15 resence of either FLAG octapeptide or bovine serum albumin.

16 cid, dopamine, uric acid, glucose and bovine serum albumin.

17 elittin, cytochrome c, myoglobin, and bovine serum albumin.

18 Serum calcium was corrected for serum albumin.

19 ds and transcription factors (TFs) and human serum albumin.

20 sis of peptides from trypsin digested bovine serum albumin.

21 coli cells and does not interact with bovine serum albumin.

22 ne-derivatized fluorophore-conjugated bovine serum albumin.

23 glycine, and beta-mercaptoethanol) and human serum albumin.

24 n, beta-lactoglobulin, soy protein and human serum albumin.

25 unfolding pathway for a group of homologous serum albumins.

26 thetic dimer between cytochrome c and bovine serum albumin, a 30% yield of the purified, isolated dim

27 Surprisingly, serum albumin acted independently of elevated Ca(2+) and

28 Tartrazine enhanced the stability of both serum albumins against thermal denaturation.

29 cting pressure ulcers: days in the hospital, serum albumin, age, blood urea nitrogen, and total Brade

30 cation using electrospun amyloid like-bovine serum albumin (AL-BSA) nanofibers on QCM surfaces.

31 nts and toxic electrophiles react with human serum albumin (albumin); however, the chemistry of react

32 dy mass index, haemoglobin, serum uric acid, serum albumin, albuminuria, and C reactive protein as no

33 energy flow through the structure of bovine serum albumin and allosteric interactions between remote

34 The contents of two amide-AGEs in human serum albumin and apolipoprotein A-II were significantly

35 ate the method, two protein isolates; bovine serum albumin and casein were investigated for their ava

36 passively sensitized to dinitrophenol-human serum albumin and challenged intradermally.

37 assively sensitized with dinitrophenol-human serum albumin and challenged intradermally.

38 clusters (AuQC@BSA) synthesized using bovine serum albumin and conjugated with acetylcholinesterase (

39 In ALS, serum albumin and creatinine are independent markers of

40 ysiologically relevant complex media (bovine serum albumin and fetal bovine serum).

41 to differentially charged epitopes on mouse serum albumin and human epidermal growth factor receptor

42 Notably, we found that serum albumin and IgG half-lives were clearly reduced in

43 s capable of detecting proteins, i.e., human serum albumin and lysozyme, with high specificity and se

44 with low nanomolar affinities against mouse serum albumin and several epitopes on human epidermal gr

45 , particularly including proteins other than serum albumin and substances beyond perfluorooctanoic ac

46 ing the extent of linker-payload transfer to serum albumin and the first clear example of in vivo for

47 ison of lipid binding to the soluble protein serum albumin and to the integral membrane protein NapA

48 and urine protein-to-creatinine ratio; lower serum albumin and urine sodium-to-potassium ratio; slowe

49 tein chromophores) using transport proteins (serum albumins and alpha1-acid glycoproteins) as hosts.

50 trated the use of an array of cross-reactive serum albumins and fluorescent indicators with chemometr

51 erent substrates: collagen-I (Col-I), bovine serum albumin, and a monolayer of bone marrow-derived st

52 rom three model proteins, hemoglobin, bovine serum albumin, and beta-casein, and compare the results

53 ic blood pressure, diastolic blood pressure, serum albumin, and bipolar disorder.

54 encapsulate a model globular protein, bovine serum albumin, and calculate its loading efficiency usin

55 pha-livetin, which is identical with chicken serum albumin, and gamma-livetin, the bioactive antibody

56 oteins, alphaB-crystalline (alphaBc), bovine serum albumin, and hen egg-white lysozyme (HEWL) in aque

57 ss in samples of bovine serum albumin, human serum albumin, and lysozyme.

58 les) with proteins (human transferrin, human serum albumin, and ovalbumin).

59 of congestive heart failure, and hemoglobin, serum albumin, and serum phosphorus levels.

60 opylene glycol (PPG), angiotensin II, bovine serum albumin, and the "thermometer" compound p-methoxyb

61 tive growth inhibitors--chondroitin sulfate, serum albumin, and transferrin--using analytical techniq

62 -acetylcysteine, captopril, bovine and human serum albumins, and hydrogen sulfide, are reported.

63 heir force curves, while PC3 cells on bovine-serum-albumin- and antibody-treated PC3 cells showed lon

64 ed via the covalent immobilization of bovine serum albumin antibody (anti-BSA) and fibrinogen antibod

65 ed fatty acids (NEFAs), transported bound to serum albumin, are associated with type 2 diabetes (T2D)

66 Furthermore, using bovine serum albumin as a model protein, the trivalent organic

67 That was similarly observed for bovine serum albumin at a subcritical water temperature of 207

68 utcomes, administration of ultra-clean human serum albumin at protein concentrations equivalent to th

69 ress this clinical need, gold cluster bovine serum albumin (AuNC@BSA) nanogates were engineered on me

70 y conjugation of azide functionalized bovine serum albumin (azido-BSA) with azido-fluorescein and by

71 This work examines the use of serum-albumin-based freestanding mats as macroscopic ele

72 e initiate this effort by considering bovine serum albumin because it is a globular protein whose sol

73 ent of supercharging was probed using bovine serum albumin, beta-lactoglobulin, and lysozyme, each of

74 Human serum albumin binding assays indicated that the retained

75 y employ the LN-IMS system to examine bovine serum albumin binding to gold nanoparticles.

76 as a proteolysis-resistant amide mimic and a serum albumin-binding motif, respectively.

77 ptide, which lies in Subdomain IIIA of human serum albumin, blocks binding of all three antibodies to

78 Bovine serum albumin (BSA) adsorption was studied at different

79 Bovine serum albumin (BSA) and dextran varying in molecular wei

80 ace properties with various proteins (bovine serum albumin (BSA) and different forms of hemoglobin).

81 y (PPC) using two different proteins [bovine serum albumin (BSA) and gelatin], molecular weights, tot

82 nd biodegradability, albumins such as bovine serum albumin (BSA) and human serum albumin (HSA) have f

83 siologically relevant components like bovine serum albumin (BSA) and lipopolysaccharide.

84 tested in a model system composed of bovine serum albumin (BSA) and methylglyoxal (MGO).

85 shells comprising alternate layers of bovine serum albumin (BSA) and tannic acid (TA) were tested as

86 tting gold nanoclusters (AuNCs) using bovine serum albumin (BSA) as a protecting agent.

87 sted for the sensing of biomolecules (bovine serum albumin (BSA) as reference) binding to gate-immobi

88 ted the interaction of CA and MC with bovine serum albumin (BSA) at pH 3.5, 5.0, and 7.4 using fluore

89 d simultaneously during adsorption of bovine serum albumin (BSA) at the surface of the K(+)-ISEs.

90 The variables of interest, such as bovine serum albumin (BSA) concentration, incubation times and

91 reated with palmitate (50 mumol/L) or bovine serum albumin (BSA) for 24 hr.

92 ) and dodecyl maltoside (DDM) protect bovine serum albumin (BSA) from unfolding in SDS.

93 the mechanism of SA interaction with bovine serum albumin (BSA) has been investigated by multi-spect

94 ent and in vitro release behaviour of bovine serum albumin (BSA) in chitosan-tripolyphosphate (TPP) h

95 eobroma cacao, L.) seeds and added to bovine serum albumin (BSA) individually and combined as mixture

96 he migration of fluorescently labeled bovine serum albumin (BSA) into the nanoslits; and fluorescence

97 F) ultrafiltration (UF) membranes and bovine serum albumin (BSA) over a range of ionic strengths.

98 etection of acetylcholine (ACh) using bovine serum albumin (BSA) protected atomically precise cluster

99 endent adsorption and denaturation of bovine serum albumin (BSA) protein onto a silica-coated array o

100 ANS complexation by cyclodextrins or bovine serum albumin (BSA) results in a nonhomogeneous solvatio

101 ient way; LC-MS of a trypsin-digested bovine serum albumin (BSA) sample provided narrow peaks, short

102 biocompatible nanocomposite including bovine serum albumin (BSA) template Cu nanoclusters (CuNCs@BSA)

103 s demonstrated that the adsorption of bovine serum albumin (BSA) to aqueous gold colloids can be quan

104 We illustrate a method that uses bovine serum albumin (BSA) to control the receptor-accessible p

105 d graphite in water by using protein, bovine serum albumin (BSA) to produce single-layer nanosheets,

106 As a case study, we choose to monitor bovine serum albumin (BSA) unspecific adsorption, which has bee

107 e interaction between glutathione and bovine serum albumin (BSA) using ultraviolet-visible (UV-vis) a

108 ining the heat denaturation degree of bovine serum albumin (BSA) was assessed.

109 In this system, bovine serum albumin (BSA) was immobilized on gold grids as the

110 he interaction between Allura Red and bovine serum albumin (BSA) was studied in vitro at pH 7.4.

111 immobilized via EDC-NHS chemistry and Bovine serum albumin (BSA) was used for blocking of the non-spe

112 The third electrode covered with Bovine Serum Albumin (BSA) was used for the control of non-spec

113 ated onto polystyrene well plates and bovine serum albumin (BSA) was used to block unsaturated bindin

114 ion followed by a post-treatment with bovine serum albumin (BSA) which served as the blocking agent t

115 tudy, we evaluated the interaction of bovine serum albumin (BSA) with AP and AS using surface plasmon

116 ted by carrying out the hydrolysis of bovine serum albumin (BSA) within 1h, and the assay was perform

117 t a protein (cytochrome c (Cytc c) or bovine serum albumin (BSA)) can be employed to gate fluorescenc

118 chrome C (Cyt-C), myoglobin (MYO) and bovine serum albumin (BSA)) have been used to evaluate the effe

119 psin Inhibitor (TI); Ovalbumin (OVA); Bovine Serum Albumin (BSA)), we observe resolution of the marke

120 Compared to Y-tube compartments with bovine serum albumin (BSA), GDNF and NGF increased the motor an

121 After conjugation to bovine serum albumin (BSA), glycoconjugates 1 to 6 were used to

122 t-inactivated CPE, antibody alone, or bovine serum albumin (BSA), indicating that increased osmolarit

123 roteins including chymotrypsin (chy), bovine serum albumin (BSA), lysozyme (lyz) and cytochrome c (cy

124 solutions), unspecific adsorption of bovine serum albumin (BSA), or specific lectin binding on glyco

125 deposited gold film and adsorption of bovine serum albumin (BSA), respectively, on poly(methyl methac

126 , with or without spiked additions of Bovine Serum Albumin (BSA), showed considerable disagreement.

127 -organophosphate hydrolase (ELP-OPH), bovine serum albumin (BSA), titanium dioxide nanofibers (TiO2NF

128 Bovine serum albumin (BSA), whey protein isolate (WPI), insulin

129 polymerization from the model protein bovine serum albumin (BSA).

130 HSA), fatty acid free HSA (ffHSA) and bovine serum albumin (BSA).

131 urified proanthocyanidin oligomers to bovine serum albumin (BSA).

132 = 0.825) with tannin precipitation by bovine serum albumin (BSA).

133 rds breast cancer antigen CA-15.3 and bovine serum albumin (BSA).

134 dence in detail for the model protein bovine serum albumin (BSA).

135 in (BLG), alpha-lactalbumin (ALA) and bovine serum albumin (BSA).

136 was conjugated to the amino groups of bovine serum albumin (BSA).

137 m or serum-derived components such as bovine serum albumin (BSA).

138 a simulated biothreat scenario using bovine serum albumin (BSA).

139 prepared from inherent biocompatible bovine serum albumin (BSA).

140 Bovine serum albumin (BSA)/curcumin binding and dye photodegrad

141 RAP) and anti-glycation activity by a bovine serum albumin (BSA)/fructose model system.

142 vity of extracts was evaluated in the bovine serum albumin (BSA)/glucose system.

143 from a simulated tryptic digest with bovine serum albumin (BSA:casein, 100:1).

144 e, sex, time from diagnosis, proteinuria, or serum albumin, but epitope spreading strongly correlated

145 ng affinity between drug molecules and human serum albumin by combining nanoporous anodic alumina rug

146 Further studies are required to confirm that serum albumin can be used as a biomarker to monitor dise

147 y precise gold clusters, Au@BSA (BSA, bovine serum albumin), coated on Nylon-6 nanofibers were used f

148 These include serum albumin, collagen and myosin.

149 Additional adjustment for serum albumin concentration substantially attenuated the

150 Serum albumin concentration was determined before and af

151 sclerosis on initial biopsy as well as age, serum albumin concentration, and CKD stage at onset affe

152 with greater prognostic accuracy than total serum albumin concentration.

153 yptic digests of three model proteins (Human Serum Albumin, creatine kinase, and myoglobin).

154 protein (PGRP) were not detected while camel serum albumin (CSA) was significantly diminished.

155 In diabetes, hepatic production of serum albumin decreases, and it has been long establishe

156 as densely immobilized conjugates of bovine serum albumin (DNP-BSA) or mobile in a supported lipid b

157 The binding modes to equine serum albumin (ESA) of two nonsteroidal anti-inflammator

158 We encapsulated fluorescent-bovine serum albumin (FITC-BSA) inside the gel.

159 rance of (13)C-PEG and PEGylated-BSA (bovine serum albumin) following their intravenous injection in

160 ecause of the high binding affinity of human serum albumin for fatty acids.

161 tochrome c, ubiquitin, myoglobin, and bovine serum albumin formed by electrospray ionization are meas

162 PABC-auristatin ultimately is transferred to serum albumin, forming a long-lived albumin-linker-paylo

163 A aptamers specifically bound glycated human serum albumin (GHSA), which is an intermediate marker fo

164 es (the three major glycated amino acids) of serum albumin, glyceraldehyde-3-phosphate dehydrogenase,

165 oreover, a protein mixture containing bovine serum albumin, GST, and ubiquitin could be specifically

166 lications were older, had lower preoperative serum albumin, had worse functional status, and had high

167 body weight, midarm and calf circumference, serum albumin, handgrip strength (HGS), and patient-self

168 The interactions of such compounds, with serum albumins, have been studied.

169 proteins such as beta-lactoglobulin A, human serum albumin, hemoglobin, and human carbonic anhydrase

170 ication, diabetes mellitus, serum potassium, serum albumin, high-density lipoprotein, estimated glome

171 othrombin time (HR 0.79; 95% CI: 0.70-0.90), serum albumin (HR 0.97; 95% CI: 0.94-0.99), and esophage

172 simple post-adsorption of human serum:bovine serum albumin (HS:BSA) mixtures onto the folic acid modi

173 individual PFOS and PFOA isomers with human serum albumin (HSA) and (ii) relative binding affinity o

174 ith 10% dimethyl sulfoxide (DMSO), 15% human serum albumin (HSA) and 0.1% hyaluronans.

175 C. diphtheriae was also able to use human serum albumin (HSA) and myoglobin (Mb) but not hemopexin

176 rugate filters (NAA-RFs) modified with human serum albumin (HSA) and reflectometric interference spec

177 estosterone and its transport proteins human serum albumin (HSA) and sex hormone binding globulin (SH

178 rchical structure for determination of human serum albumin (HSA) are designed and fabricated.

179 thesized using the circulatory protein human serum albumin (HSA) as a template, whose synthetic proce

180 ghly disulfide-bonded proteins such as human serum albumin (HSA) by online EC reduction of nonreduced

181 Glycation of human serum albumin (HSA) can also be measured using this tech

182 olecularly imprinted polymer (MIP) for human serum albumin (HSA) determination using semi-covalent im

183 ecifically to enhance interaction with human serum albumin (HSA) for drug delivery.

184 etics and affinities of fibrinogen and human serum albumin (HSA) for TiO2, CeO2, Al2O3 and ZnO NPs im

185 an A2, C1, and C2 domains presented as human serum albumin (HSA) fusion proteins.

186 such as bovine serum albumin (BSA) and human serum albumin (HSA) have found a wide range of biomedica

187 profiled adducts at the Cys34 locus of human serum albumin (HSA) in 29 nonsmoking Xuanwei and Fuyuan

188 The label-free detection of human serum albumin (HSA) in aqueous buffer is demonstrated us

189 = 200 nm) which selectively respond to human serum albumin (HSA) in the presence of other thiol-conta

190 Human serum albumin (HSA) interacts with this family of compou

191 Human serum albumin (HSA) is a natural carrier protein possess

192 as detected on four lysine residues of human serum albumin (HSA) isolated from tolerant patients.

193 for PSMA and appropriate affinity for human serum albumin (HSA) may demonstrate a higher therapeutic

194 we loaded ATO onto folate (FA)-labeled human serum albumin (HSA) pretreated with glutathione (GSH) ba

195 d (SM) produces a covalent adduct with human serum albumin (HSA) representing an established plasma b

196 Trypsin-digested, SDA-cross-linked human serum albumin (HSA) served as a test sample, yielding ov

197 Human serum albumin (HSA) serves as a convenient and easily re

198 Human serum albumin (HSA) serves not only as a physiological o

199 kage of dibenzocyclooctyne-derivatized human serum albumin (HSA) through strain-promoted azide-alkyne

200 ty-lipoprotein (VLDL) yields 1-3%, and human serum albumin (HSA) yields 0-2%.

201 le starts with a brief introduction of human serum albumin (HSA), and then summarizes the mainstream

202 albumins have been considered, namely human serum albumin (HSA), fatty acid free HSA (ffHSA) and bov

203 uman Kallikrein 2) and low response to human serum albumin (HSA), suggesting possible resilience to t

204 inhibitor of Abeta self-association is human serum albumin (HSA), which binds approximately 90% of pl

205 , bovine thyroglobulin (Bos d TG), and human serum albumin (HSA)-conjugated alpha-Gal.

206 cribe the interaction between 2PHE and human serum albumin (HSA).

207 s of unusually long serum half-life of human serum albumin (HSA).

208 ins, of which the most abundant in humans is serum albumin (HSA).

209 M(-1) s(-1) upon binding to Zn(II) and human serum albumin (HSA).

210 ctures with strong binding affinity to human serum albumin (HSA).

211 serum albumin [MAA]) and (99m)Tc-HSA (human serum albumin [HSA]), was assessed.

212 g the glycation process in samples of bovine serum albumin, human serum albumin, and lysozyme.

213 bining administration of an engineered mouse serum albumin/IL-2 fusion with an Fc fusion to an integr

214 a test line comprised of the protein bovine serum albumin immobilized on nitrocellulose.

215 ious membrane transporters, association with serum albumin in circulatory and extracellular spaces, a

216 ike peptide-1 (GLP-1) analogue that binds to serum albumin in vivo and is approved for once-daily tre

217 lysozyme and all 17 disulfide bonds in human serum albumin, including nested disulfide bonds and moti

218 The natural agonist serum albumin induced microneme secretion in a protein k

219 protein interactions are important, and that serum albumin is only one of a number of proteins contro

220 m dissociation constant for Zn(2+) and human serum albumin (Kd = (5.62 +/- 0.93) x 10(-7) M) under ph

221 Bovine serum albumin, lactoferrin, and alpha-casein (S1 and S2

222 rum beta2-microglobulin level < 3.5 mg/L and serum albumin level >/= 3.5 g/dL), no high-risk CA [del(

223 lue resulted in sustained improvement of the serum albumin level and symptoms in 3 patients, temporar

224 lbumin level than men, and stratification by serum albumin level attenuated sex differences in the ag

225 ing treatment with IVIG (2 g/kg), the median serum albumin level decreased to 3.7 g/dL (interquartile

226 el of 82 g/L (reference range, 66-81 g/L), a serum albumin level of 39.3 g/L (reference range, 40.2-4

227 Women had a significantly lower serum albumin level than men, and stratification by seru

228 Before treatment, the median serum albumin level was 4.2 g/dL (interquartile range, 3

229 0.01 g/dl (95% CI 0.0004-0.02; p < 0.04) in serum albumin level, and 0.03 g/dl (95% CI 0.008-0.05; p

230 ologic conditions to minimize alterations in serum albumin level.

231 or differences in health status reflected by serum albumin level.

232 sitive unlike normal Fc interactions and how serum albumin levels are unaffected by DX-2507 binding.

233 Serum albumin levels were determined in 174 patients wit

234 sess whether there is an association between serum albumin levels, a widely used and relatively easil

235 ts low energy and protein intake, as well as serum albumin levels, biomarkers of malnutrition in CKD.

236 ibrinogen in the presence of high background serum albumin levels.

237 Conjugation of fatty acid, a natural human serum albumin ligand, to a therapeutic protein/peptide w

238 s that interactions with proteins--including serum albumin, liver fatty acid binding proteins (L-FABP

239 ctivity against other proteins such as human serum albumin, lysozyme and insulin.

240 umin compounds, (99m)Tc-MAA (macroaggregated serum albumin [MAA]) and (99m)Tc-HSA (human serum albumi

241 Because the hemin-doped serum albumin mats have both biocompatibility and fabric

242 Free-standing serum-albumin mats can transport protons over millimetre

243 Methylated-bovine serum albumin (mBSA), but not vehicle challenge, in the

244 mice were immunized with MDA-adducted bovine serum albumin (MDA-BSA) before feeding the MCD diet.

245 Only serum albumin (men: </= 4.3 vs >4.3 mg/dL, P < .001; wom

246 sed for recording the binding between Bovine Serum Albumin molecules immobilized onto the surface and

247 oteins, such as transferrin, heparin, bovine serum albumin, mucin, or collagen IV.

248 than 95% of model biochemical species (human serum albumin, neurotensin, creatinine, glycine, and ala

249 nding of cis-[Ru(phen)2(ImH)2](2+) and human serum albumin occurs via noncovalent interactions with K

250 tered when the assay was processed in bovine serum albumin or human serum.

251 albumin (p = 0.035) predicted PEF while low serum albumin (p = 0.021) and low platelet counts (p = 0

252 elevated serum bilirubin (p = 0.046) and low serum albumin (p = 0.035) predicted PEF while low serum

253 suggest that oxo-amino-acids of the protein serum albumin play a major role in the translocation of

254 by sequential immobilization of UPEC, bovine serum albumin, primary antibody and Horse Radish Peroxid

255 termined that an in-line injection of bovine serum albumin prior to analyte injection yielded the mos

256 induced fluorescence quenching of the bovine serum albumin-protected Au25 nanoclusters (BSAGNCs).

257 alent binding of biopharmaceuticals to human serum albumin protects against enzymatic degradation and

258 patinib release from a nanoshell-based human serum albumin protein host complex resulted in increased

259 ase, one from creatine kinase, and four from serum albumin protein.

260 roaches, allowing us to detect single bovine serum albumin proteins with a molecular weight of 66 kDa

261 for both trypsin and Lys C digests of bovine serum albumin, providing ECD spectra for doubly charged

262 unosensor for sensitive detection of porcine serum albumin (PSA) is reported in this work.

263 evaluating the cerebrospinal fluid (CSF) to serum albumin quotient (QAlb) in patients with primary H

264 cularly imprinted polymer coated with bovine serum albumin (RAMIP-BSA) was synthesized, characterized

265 were Glasgow coma and outcome scores; CSF to serum albumin ratio, reflecting BBB permeability; and, i

266 ammation, alkaline phosphatase activity, low serum albumin, renal function, and inorganic phosphate.

267 g and specific affinity of recombinant human serum albumin (rHSA) towards cholesteryl-modified siRNA

268 and positive co-protein effects with bovine serum albumin, (S-)ovalbumin, egg white, whole egg, defa

269 However, serum albumin (SA) and IgG, through its Fc part, bind to

270 nd replaced with an equal volume of 5% human serum albumin-saline mixture) to reduce [Hb] (Low [Hb]).

271 ensor is 3 orders of magnitude higher in the serum albumin solution than that only in the buffer solu

272 e of free fatty acids (FFAs) associated with serum albumin stimulated macropinocytosis through a path

273 tate on structures of native-like cations of serum albumin, streptavidin, avidin, and alcohol dehydro

274 ely affected by beta-cyclodextrin and bovine serum albumin, taken as models of food macromolecules.

275 easurements clearly indicate that the bovine serum albumin tertiary structure changes as protein conc

276 gher solubilities and lower binding to human serum albumin than that of Mocetinostat.

277 n an order of magnitude tighter than that of serum albumin, the extracellular Cu(2+) transport protei

278 relatively little attention has been paid to serum albumin, the main blood protein, even though blood

279 the intrinsic transport properties of human serum albumin to tune the blood circulatory half-life, h

280 t it utilizes coating agents, such as bovine serum albumin, to create consistent rotation and vibrati

281 Using the strong affinities of serum albumins towards anions, the increase in cathodic

282 In all VKC samples, levels of serum albumin, transferrin, and hemopexin were found up

283 oth mixtures of small molecules and a bovine serum albumin tryptic digest, TASF improved the peak sha

284 (GSC) and PT uptake of Texas Red-labeled rat serum albumin using two-photon intravital microscopy.

285 Median laboratory MELD was 15, serum albumin was 3.0 g/dL, 28% had ascites, 18% had hep

286 In patients with ALS, serum albumin was correlated with markers of inflammator

287 Finally, human serum albumin was found to bind NO2-CLA both non-covalen

288 In this study, serum albumin was hydrolysed with trypsin after several

289 total chemical delivery time, labeled bovine serum albumin was injected in the channel chamber and TI

290 re, the interaction between KP1019 and human serum albumin was investigated by means of X-ray crystal

291 Using this method, a model protein bovine serum albumin was investigated over 3 days of incubation

292 Serum albumin was measured from January 13 to 20, 2011.

293 rms upon exposure of nanoparticles to bovine serum albumin was utilized as a nanoparticle stabilizati

294 Only Ag-NPs functionalized with BSA (bovine serum albumin), which is a protein with the function to

295 sing is inhibited by physiological levels of serum albumin, which appears to bind and sequester some

296 Serum albumin, which has been shown to degrade and inact

297 blood proteins, particularly Cys34 of human serum albumin, which is the dominant scavenger of reacti

298 -specific antibody linked in tandem to human serum albumin, which retained FcgammaR-binding activity

299 ock perfluorooctanesulfonate (PFOS) to human serum albumin with deviations smaller than 2 A.

300 ibody binding site, HSA Peptide 40, on human serum albumin with nanomolar affinity for all three mono